Get the Stockscreener App
1.13
5.83%
-0.07
After Hours:
1.12
-0.010
-0.88%
Enlivex Ltd stock is traded at $1.13, with a volume of 105.63K.
It is down -5.83% in the last 24 hours and down -2.59% over the past month.
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.
See More
Previous Close:
$1.20
Open:
$1.17
24h Volume:
105.63K
Relative Volume:
0.19
Market Cap:
$268.24M
Revenue:
-
Net Income/Loss:
$-14.33M
P/E Ratio:
-1.7121
EPS:
-0.66
Net Cash Flow:
$-13.21M
1W Performance:
-1.74%
1M Performance:
-2.59%
6M Performance:
+6.60%
1Y Performance:
+0.00%
1-Day Range:
$1.12
$1.18
1-Week Range:
$1.09
$1.20
52-Week Range:
$0.66
$2.10
Enlivex Ltd Stock (ENLV) Company Profile
Compare ENLV vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENLV
Enlivex Ltd
|
1.13 | 284.86M | 0 | -14.33M | -13.21M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.14 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Enlivex Ltd Stock (ENLV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-02-21 | Reiterated | H.C. Wainwright | Buy |
Enlivex Ltd Stock (ENLV) Latest News
Operating cash flow per share of Enlivex Ltd. – SWB:1BT - TradingView
Enlivex Therapeutics Ltd expected to post a loss of 16 cents a shareEarnings Preview - TradingView
ENLV Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Palm Beach Daily News
Enlivex Therapeutics (NASDAQ:ENLV) Rating Increased to Hold at Wall Street Zen - Defense World
Enlivex Ltd.: Target Price Consensus and Analysts Recommendations | 1BT | IL0011319527 - marketscreener.com
Enlivex Ltd.: Financial Data Forecasts Estimates and Expectations | 1BT | IL0011319527 - marketscreener.com
1BT: Static price chart | Enlivex Ltd. | IL0011319527 - marketscreener.com
Enlivex Ltd.: Dividend historical data and projections - marketscreener.com
Enlivex Ltd.: Revenue and Earnings Analysts Forecasts Revisions | 1BT | IL0011319527 - marketscreener.com
Enlivex Ltd.: Performance & Quotes, 1BT Stock Price on Börse Stuttgart Exchange - marketscreener.com
Enlivex Ltd.: Target Price Consensus and Analysts Recommendations | ENLV | IL0011319527 - marketscreener.com
Enlivex Ltd.: Revenue and Earnings Analysts Forecasts Revisions | ENLV | IL0011319527 - marketscreener.com
Enlivex Ltd.: Shareholders Board Members Managers and Company Profile | IL0011319527 - marketscreener.com
Enlivex Ltd.: Financial Data Forecasts Estimates and Expectations | ENLV | IL0011319527 - marketscreener.com
ENLV: Static price chart | Enlivex Ltd. | IL0011319527 - marketscreener.com
Enlivex Ltd.: Performance & Quotes, ENLV Stock Price on Nasdaq Exchange - marketscreener.com
Aug Closing: Is Enlivex Therapeutics Ltd forming a bullish divergenceIndex Update & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Enlivex Rebrands as Enlivex Ltd. Following Shareholder Approval - TipRanks
Enlivex (ENLV) shareholders approve and complete corporate name change - Stock Titan
Enlivex Therapeutics (ENLV) to Release Quarterly Earnings on Wednesday - Defense World
Can Enlivex Therapeutics Ltd. reach all time highs this yearJuly 2025 Closing Moves & Fast Exit Strategy with Risk Control - mfd.ru
Enlivex Therapeutics Ltd. (ENLV) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Aug Drivers: Is QVCGB stock overvalued or fairly pricedWeekly Gains Summary & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
ENLV to Participate in Virtual Meeting Hosted by BTIG - GuruFocus
Will Enlivex Therapeutics Ltd. stock benefit from infrastructure spendingForecast Cut & Short-Term High Return Ideas - mfd.ru
Enlivex Therapeutics (NASDAQ:ENLV) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat
Volatile Outlook for Enlivex Therapeutics as Investors Await Clinical Catalysts - Born2Invest
Enlivex Therapeutics Ltd. (NASDAQ:ENLV) Short Interest Update - MarketBeat
Enlivex Therapeutics announces new listing of RAIN token on Kraken - Yahoo Finance
Activity Recap: What are Enlivex Therapeutics Ltd.’s growth leversBear Alert & Free Verified High Yield Trade Plans - mfd.ru
Will Enlivex Therapeutics Ltd. outperform its industry peers2025 Investor Takeaways & Technical Pattern Based Signals - mfd.ru
Enlivex Completes $212 Million Private Placement, Expands Digital Asset Strategy - MSN
Enlivex Therapeutics (ENLV) Expands RAIN Token Accessibility wit - GuruFocus
Enlivex’s RAIN Treasury Token Debuts on Kraken to Boost Liquidity - TipRanks
Enlivex Treasury Portfolio Update: New Listing of the RAIN Token on Kraken, the Second-Largest U.S. Cryptocurrency Exchange - The Manila Times
Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Asheville Citizen Times
Enlivex Shareholders Approve Amended Articles of Association at February 3 Meeting - The Globe and Mail
Enlivex Completes Private Placement to Fund Digital Asset Strategy - MSN
Short Interest in Enlivex Therapeutics Ltd. (NASDAQ:ENLV) Drops By 66.6% - MarketBeat
Enlivex Lists RAIN Treasury Token on WhiteBIT to Boost Liquidity - The Globe and Mail
Enlivex Therapeutics (ENLV) Expands Reach with RAIN Token Listin - GuruFocus
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on WhiteBIT, a Leading Cryptocurrency Exchange - The Manila Times
Token powering real-world events markets lands on Europe’s top crypto exchange - Stock Titan
Analyst Upgrade: Is ProShares Trust ProShares Short Russell2000 forming bullish engulfing patternsWeekly Investment Recap & Community Driven Trade Alerts - baoquankhu1.vn
Can Enlivex Therapeutics Ltd sustain earnings growthMarket Movers & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
Enlivex Therapeutics to delist from Tel Aviv Stock Exchange in April By Investing.com - Investing.com India
Enlivex Therapeutics Shares to Trade Exclusively on Nasdaq - MEXC
Enlivex Shares to Trade Exclusively on NASDAQ - Baystreet.ca
Enlivex Therapeutics to delist from Tel Aviv Stock Exchange in April - Investing.com Australia
Enlivex to Delist from Tel Aviv and Shift Trading Exclusively to Nasdaq - TipRanks
Enlivex Ltd Stock (ENLV) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.69%
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):